Suven Pharmaceuticals consolidated net profit declines 49.61% in the June 2024 quarter
Sales decline 33.62% to Rs 230.69 crore
Net profit of Suven Pharmaceuticals declined 49.61% to Rs 60.77 crore in the quarter ended June 2024 as against Rs 120.59 crore during the previous quarter ended June 2023. Sales declined 33.62% to Rs 230.69 crore in the quarter ended June 2024 as against Rs 347.55 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales230.69347.55 -34 OPM %34.6548.04 -PBDT96.49176.48 -45 PBT83.09163.94 -49 NP60.77120.59 -50Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 09 2024 | 4:00 PM IST